Utilizing this pharmacological probe, we demonstrated that the selective inhibition of CBS could suppress cell proliferation, cause cell cycle arrest at S phase and significantly reduce in vivo tumor growth in tumor xenograft mice model. Here, CBS is linked to neoplasm.